Clinical trial
AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT02420587
Study timeline
Study start (unknown)2014-10-01Date precision: month
Registry last updated2015-04-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
AMG 208DRUG
QuestionnaireBEHAVIORAL
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Amgencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02420587 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.